→
GE Healthcare's current price of $63.72 reflects a 0.84% decrease from the previous close of $64.26, with a market cap of $29.23B. The company's revenue growth of 5.97% year-over-year contrasts with a concerning EPS decline of 12.27%, indicating a mixed performance, which is reflected in the analyst consensus of 8 Strong Buy and 10 Buy ratings.
Given the mixed signals, a hold recommendation is prudent until clearer trends in earnings performance emerge.
If GE Healthcare can stabilize its earnings and return to positive EPS growth, the stock could rebound towards its 52-week high of $89.77, representing a potential upside of 40.5%. Additionally, sustained revenue growth could improve investor sentiment and drive share prices higher.
Conversely, the decline in EPS by 12.27% year-over-year raises concerns about profitability, which could lead the stock to test its 52-week low of $58.75, indicating a downside of approximately 7.8%. A continued miss on earnings estimates could further erode confidence among investors.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Helm's AI rates GEHC as Neutral. Given the mixed signals, a hold recommendation is prudent until clearer trends in earnings performance emerge.
Conversely, the decline in EPS by 12.27% year-over-year raises concerns about profitability, which could lead the stock to test its 52-week low of $58.75, indicating a downside of approximately 7.8%. A continued miss on earnings estimates could further erode confidence among investors.
If GE Healthcare can stabilize its earnings and return to positive EPS growth, the stock could rebound towards its 52-week high of $89.77, representing a potential upside of 40.5%. Additionally, sustained revenue growth could improve investor sentiment and drive share prices higher.
GE Healthcare's current price of $63.72 reflects a 0.84% decrease from the previous close of $64.26, with a market cap of $29.23B. The company's revenue growth of 5.97% year-over-year contrasts with a concerning EPS decline of 12.27%, indicating a mixed performance, which is reflected in the analyst consensus of 8 Strong Buy and 10 Buy ratings.
GE Healthcare's current price of $63.72 reflects a 0.84% decrease from the previous close of $64.26, with a market cap of $29.23B. The company's revenue growth of 5.97% year-over-year contrasts with a concerning EPS decline of 12.27%, indicating a mixed performance, which is reflected in the analyst consensus of 8 Strong Buy and 10 Buy ratings. Our overall verdict is Neutral.
Helm Terminal offers free AI-powered stock analysis for GEHC at helmterminal.dev/analyze/GEHC, updated continuously during US market hours. No signup required.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.